Petros Pharmaceuticals Inc (PTPI)
0.6701
-0.03
(-3.98%)
USD |
NASDAQ |
Apr 19, 16:00
0.6701
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 75.61% |
| June 30, 2023 | 74.23% |
| March 31, 2023 | 78.13% |
| December 31, 2022 | -10.43% |
| September 30, 2022 | |
| June 30, 2022 | 84.49% |
| March 31, 2022 | 80.84% |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | 85.12% |
| June 30, 2021 | 84.00% |
| March 31, 2021 | 84.21% |
| December 31, 2020 | 40.56% |
| September 30, 2020 | 71.66% |
| June 30, 2020 | 60.74% |
| March 31, 2020 | 56.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-10.43%
Minimum
Dec 2022
85.12%
Maximum
Sep 2021
66.57%
Average
75.61%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -- |
| Spectral AI Inc | 42.79% |
| Imunon Inc | -- |
| Assembly Biosciences Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.15% |
| Return on Assets | -24.82% |
| Return on Invested Capital | -37.66% |
| Profit Margin (Quarterly) | -87.34% |
| Return on Net Operating Assets | -29.72% |